文献速递心外重症与机械循环支持

体外膜氧合治疗大块肺栓塞所致心肺衰竭的中期结局

Mid-term outcomes with the use of extracorporeal membrane oxygenation for cardiopulmonary failure secondary to massive pulmonary embolism.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

本研究回顾性分析36例因急性肺栓塞需ECMO支持的患者(32例VA-ECMO,4例VV-ECMO),出院生存率44.4%,出院后2年生存率94%。近期手术和撤机时低左室射血分数是院内死亡的独立危险因素,存活出院者中期功能状态和生活质量可接受。

要点

  • 大块肺栓塞需ECMO者早期死亡率高,出院生存率44.4%。
  • 出院后2年生存率94%,存活者功能状态和生活质量可接受。
  • 近期手术和撤机时低LVEF是院内死亡的独立危险因素。

核心结论

  • 大块急性肺栓塞需ECMO支持者早期死亡率高,但存活出院者中期结局良好。

研究设计与样本

  • 回顾性研究,纳入36例急性肺栓塞后需ECMO的患者,其中VA-ECMO 32例,VV-ECMO 4例。

主要发现

  • 总体出院生存率为44.4%(16/36),出院后2年生存率为94%(15/16)。
  • VA-ECMO后2年生存率为39%(13/32),VV-ECMO出院生存率为50%。
  • 单因素分析中,近期手术(P=0.064)、低左室射血分数(P=0.029)、撤机时右室功能障碍≥中度(P=0.083)、ECMO置入时持续心肺复苏(P=0.053)和撤机时乳酸升高(P=0.002)为院内死亡危险因素。
  • 多因素分析中,近期手术(P=0.018)和撤机时低左室射血分数(P=0.013)是院内死亡的独立相关因素。
  • 中位随访23个月,10例受访者功能状态和生活质量均可接受。

关键数值与推荐

  • 出院生存率44.4%(16/36),出院后2年生存率94%(15/16)。
  • VA-ECMO后2年生存率39%(13/32)。
  • VV-ECMO出院生存率50%。
  • 多因素分析:近期手术P=0.018,撤机时低LVEF P=0.013。

临床怎么用

  • ECMO可作为大块肺栓塞心肺衰竭患者的稳定平台,便于实施其他干预。
  • 对近期手术或撤机时低LVEF者应警惕院内死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: There has been increasing interest in using extracorporeal membrane oxygenation (ECMO) to rescue patients with pulmonary embolism (PE) in the advanced stages of respiratory or haemodynamic decompensation. We examined mid-term outcomes and risk factors for in-hospital mortality. METHODS: We conducted a retrospective study of 36 patients who required ECMO placement (32 veno-arterial ECMO, 4 veno-venous) following acute PE. Survival curves were estimated using the Kaplan-Meier method. Risk factors for in-hospital mortality were assessed by logistic regression analysis. Functional status and quality of life were assessed by phone questionnaire. RESULTS: Overall survival to hospital discharge was 44.4% (16/36). Two-year survival conditional to discharge was 94% (15/16). Two-year survival after veno-arterial ECMO was 39% (13/32). In patients supported with veno-venous ECMO, survival to discharge was 50%, and both patients were alive at follow-up. In univariable analysis, a history of recent surgery (P = 0.064), low left ventricular ejection fraction (P = 0.029), right ventricular dysfunction ≥ moderate at weaning (P = 0.083), on-going cardiopulmonary resuscitation at ECMO placement (P = 0.053) and elevated lactate at weaning (P = 0.002) were risk factors for in-hospital mortality. In multivariable analysis, recent surgery (P = 0.018) and low left ventricular ejection fraction at weaning (P = 0.013) were independent factors associated with in-hospital mortality. At a median follow-up of 23 months, 10 patients responded to our phone survey; all had acceptable functional status and quality of life. CONCLUSIONS: Massive acute PE requiring ECMO support is associated with high early mortality, but patients surviving to hospital discharge have excellent mid-term outcomes with acceptable functional status and quality of life. ECMO can provide a stable platform to administer other intervention with the potential to improve outcomes. Risk factors for in-hospital mortality after PE and veno-arterial ECMO support were identified.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Sertic F, Diagne D, Chavez L, et al. Mid-term outcomes with the use of extracorporeal membrane oxygenation for cardiopulmonary failure secondary to massive pulmonary embolism. Eur J Cardiothorac Surg. 2020. PMID: 32725134. doi:10.1093/ejcts/ezaa189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。